Versant Ventures is a healthcare investment firm founded in 1999 and based in San Francisco, California. It focuses on supporting exceptional entrepreneurs in building innovative companies across various sectors within healthcare, including biotechnology, life sciences, pharmaceuticals, and oncology. With $2.3 billion under management, the firm invests at all stages of company development, emphasizing the discovery and development of novel therapeutics. Versant’s team possesses extensive investment, operational, and scientific expertise, allowing for a hands-on approach to company building. Since its inception, more than 65 companies associated with Versant have successfully achieved acquisitions or initial public offerings, reflecting the firm’s commitment to fostering growth in the healthcare industry.
One Sansome Street, Suite 3630 San Francisco, CA 94104
920 Broadway 16th floor New York, NY 10010
Bradley Bolzon
Managing Director
Gianni Gromo
Partner
Thomas Hudson Ph.D
Venture Partner
Katharina Kreymborg Ph.D
Principal
Bill Link
Investor
Guido Magni
Partner
Charles Warden
Managing Director
Tom Woiwode
Managing Director
Rami Hannoush Ph.D
Venture Partner
Clare Ozawa
Managing Director
Past deals in Macau
SanReno Therapeutics
Funding Round in 2021
SanReno Therapeutics specializes in the development, manufacturing, and commercialization of therapies for kidney diseases in several regions including the People's Republic of China, Hong Kong, Macau, Taiwan, and Singapore. Established through a joint venture involving Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, the company is dedicated to researching and producing innovative biotech solutions aimed at improving the quality of life for patients suffering from kidney-related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.